Merck Sharp & Dohme Corp. v. Anchen Pharmaceuticals, Inc., et al.
| Merck Sharp & Dohme Corp. |
| Par Pharmaceuticals, Inc. and Anchen Pharmaceuticals, Inc. |
| 1:2019cv00311 |
| February 13, 2019 |
| U.S. District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. § 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on November 17, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 12 ANSWER to #9 Answer to Complaint, and Counterclaims, by Merck Sharp & Dohme Corp..(Silver, Daniel) Modified on 3/29/2019 (nms). |
| Pro Hac Vice Attorneys David H. Silverstein, Aziz Burgy, and Christopher M. Gallo for Anchen Pharmaceuticals, Inc. and Par Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ddp) |
SO ORDERED, re #11 MOTION for Pro Hac Vice Appearance of Attorney David H. Silverstein, Aziz Burgy, and Christopher M. Gallo, filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/12/2019. (nms)
|
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Pro Hac Vice Attorney Anthony H. Sheh for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ddp) |
| Filing 11 MOTION for Pro Hac Vice Appearance of Attorney David H. Silverstein, Aziz Burgy, and Christopher M. Gallo - filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Fineman, Steven) |
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Endo International PLC for Par Pharmaceuticals, Inc.; Corporate Parent Par Pharmaceutical Inc. for Anchen Pharmaceuticals, Inc. filed by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc.. (Fineman, Steven) |
| Filing 9 ANSWER to #1 Complaint, , COUNTERCLAIM against Merck Sharp & Dohme Corp. by Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc..(Fineman, Steven) |
| Pro Hac Vice Attorney Jingyuan Luo for Merck Sharp & Dohme Corp. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00310-RGA et al.(ceg) |
| Filing 8 DECLARATION of Mailing regarding service on Par Pharmaceutical, Inc. made on February 14, 2019, by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibits A-B)(Silver, Daniel) Modified on 2/25/2019 (nms). |
| Filing 7 SUMMONS Returned Executed by Merck Sharp & Dohme Corp.. Anchen Pharmaceuticals, Inc. served on 2/14/2019, answer due 3/7/2019. (Silver, Daniel) |
|
SO ORDERED, re (6 in 19-cv-321-RGA, 6 in 19-cv-318-RGA, 6 in 19-cv-312-RGA, 6 in 19-cv-314-RGA, 6 in 19-cv-310-RGA, 6 in 19-cv-316-RGA, 6 in 19-cv-313-RGA, 6 in 19-cv-320-RGA, 6 in 19-cv-347-RGA, 6 in 1:19-cv-00319-RGA, 6 in 19-cv-317-RGA, 6 in 19-cv-311-RGA, 6 in 19-cv-315-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jinyuan Luo, filed by Merck Sharp & Dohme Corp.. Signed by Judge Richard G. Andrews on 2/22/2019. Associated Cases: 1:19-cv-00310-RGA et al.(nms)
|
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00310-UNA et al.(bkb) |
| Filing 6 MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Jessamyn S. Berniker, Stanley E. Fisher, Shaun P. Mahaffy, Anthony H. Sheh, and Jingyuan Luo - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Certifications)(Silver, Daniel) Modified on 2/22/2019 (nms). |
| Summons Issued with Magistrate Consent Notice attached as to Anchen Pharmaceuticals, Inc. on 2/14/2019; Par Pharmaceuticals, Inc. on 2/14/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (ddp) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme Corp. filed by Merck Sharp & Dohme Corp.. (ddp) . |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (ddp) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/13/12 and 10/22/12. Date of Expiration of Patent: 11/24/26. (ddp) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (ddp) |
| Filing 1 COMPLAINT filed against Anchen Pharmaceuticals, Inc., Par Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2569815.) - filed by Merck Sharp & Dohme Corp.. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(ddp) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
